These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11158729)

  • 1. Regulation of VanA- and VanB-type glycopeptide resistance in enterococci.
    Arthur M; Quintiliani R
    Antimicrob Agents Chemother; 2001 Feb; 45(2):375-81. PubMed ID: 11158729
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycopeptide-resistant enterococci: a decade of experience.
    Woodford N
    J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of VanA- and VanB-containing enterococci in poultry raised on nonintensive production farms in Brazil.
    Batista Xavier D; Moreno Bernal FE; Titze-de-Almeida R
    Appl Environ Microbiol; 2006 Apr; 72(4):3072-3. PubMed ID: 16598023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of glycopeptide-resistant enterococci from a Swiss hospital.
    Liassine N; Frei R; Jan I; Auckenthaler R
    J Clin Microbiol; 1998 Jul; 36(7):1853-8. PubMed ID: 9650924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
    Bell JM; Paton JC; Turnidge J
    J Clin Microbiol; 1998 Aug; 36(8):2187-90. PubMed ID: 9665988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
    Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
    J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of glycopeptide resistance in enterococci.
    Evers S; Quintiliani R; Courvalin P
    Microb Drug Resist; 1996; 2(2):219-23. PubMed ID: 9158763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrofurantoin is active against vancomycin-resistant enterococci.
    Zhanel GG; Hoban DJ; Karlowsky JA
    Antimicrob Agents Chemother; 2001 Jan; 45(1):324-6. PubMed ID: 11120989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources.
    Woodford N; Adebiyi AM; Palepou MF; Cookson BD
    Antimicrob Agents Chemother; 1998 Mar; 42(3):502-8. PubMed ID: 9517923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci.
    Arthur M; Depardieu F; Reynolds P; Courvalin P
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1875-80. PubMed ID: 10428906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms.
    Simonsen GS; Haaheim H; Dahl KH; Kruse H; Løvseth A; Olsvik O; Sundsfjord A
    Microb Drug Resist; 1998; 4(4):313-8. PubMed ID: 9988050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci.
    Patel R; Uhl JR; Kohner P; Hopkins MK; Cockerill FR
    J Clin Microbiol; 1997 Mar; 35(3):703-7. PubMed ID: 9041416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci.
    Arthur M; Depardieu F; Reynolds P; Courvalin P
    Mol Microbiol; 1996 Jul; 21(1):33-44. PubMed ID: 8843432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of glycopeptide resistant Streptococcus gallolyticus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in The Netherlands.
    Mevius D; Devriese L; Butaye P; Vandamme P; Verschure M; Veldman K
    J Antimicrob Chemother; 1998 Aug; 42(2):275-6. PubMed ID: 9738855
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci.
    Woodford N
    Microb Drug Resist; 2001; 7(3):229-36. PubMed ID: 11759084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of vanA Genotype Vancomycin-Resistant Enterococci with Low or Moderate Levels of Teicoplanin Resistance in Korea.
    Eom JS; Hwang IS; Hwang BY; Lee JG; Lee YJ; Cheong HJ; Park YH; Park SC; Kim WJ
    J Clin Microbiol; 2004 Apr; 42(4):1785-6. PubMed ID: 15071050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the VITEK 2 system with the E-test for the determination of glycopeptide susceptibility of vanA and vanC positive enterococci.
    Dombrádi Z; Bihari Z; Horváth KI; Szabó J
    Acta Microbiol Immunol Hung; 2010 Sep; 57(3):157-63. PubMed ID: 20870588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterococci and vancomycin resistance.
    French GL
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
    Jakovac S; Bojić EF; Ibrišimović MA; Tutiš B; Ostojić M; Hukić M
    Microb Drug Resist; 2017 Jan; 23(1):122-126. PubMed ID: 27351410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus.
    Dutka-Malen S; Blaimont B; Wauters G; Courvalin P
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1675-7. PubMed ID: 7979308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.